AI assistant
Sending…
Processa Pharmaceuticals, Inc. — Director's Dealing 2025
Apr 11, 2025
35172_dirs_2025-04-11_e3c3be3a-72cb-42b9-9a71-0d89c81d2bf8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-04-01
Reporting Person: Lin Patrick (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-01 | Common Stock | M | 14482 | — | Acquired | 43541 | Direct |
| 2025-04-01 | Common Stock | F | 4814 | $0.412 | Disposed | 38727 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 43500 | Indirect |
Footnotes
F1: Distribution of vested restricted shares
More from Processa Pharmaceuticals, Inc.
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 7
Regulatory Filings
2025
Dec 15
Major Shareholding Notification
2025
Nov 7
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 15